EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Allogeneic Umbilical Cord Blood Serum Eyedrops for the Treatment of Severe Dry Eye Disease Patients

Marco Zeppieri iD, Giuseppe Gagliano iD, Matteo Capobianco iD, Caterina Gagliano iD, Francesco Cappellani iD, Giuseppa Tancredi, Alessandro Avitabile iD, Ludovica Cannizzaro iD, Fabiana D'Esposito iD

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms262110782 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Marco Zeppieri und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, University Hospital of Udine, 33100 Udine, Italy. Hauptthemen laut MEDLINE: Dry Eye Syndromes, Ophthalmic Solutions, Fetal Blood, Serum. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Human allogeneic umbilical cord blood serum stands out as a potent adjunct to conventional therapies for ocular surface disorders related to severe Dry Eye Disease. By expediting ocular surface regeneration and fostering epithelial integrity, umbilical cord blood serum not only enhances subjective patient experiences but also improves objective clinical indicators. This makes it particularly useful in patients with corneal ulcers through ocular surface regeneration and anti-inflammatory activity. This retrospective, interventional, non-randomized clinical study aims to explore the efficacy of allogenic umbilical cord blood serum in patients who had previously received other treatments unsuccessfully. This study was a retrospective, non-comparative, interventional clinical study involving 55 patients (35 females and 20 males) aged 18–82 years with severe Dry Eye Disease who were unresponsive to standard treatments. The study was conducted at Eye Center “G.B. Morgagni-DSV”, Catania, Italy. Patients were categorized based on the etiology of severe Dry Eye Disease into four groups: group I consisted of 26 patients with filamentary keratitis and corneal ulcers associated with rheumatologic diseases such as Sjogren’s syndrome and systemic sclerosis; group II comprised 15 patients with graft-versus-host disease; group III consisted of 10 patients with corneal neurotrophic ulcers; group IV included four patients with Steven–Johnson syndrome. Outcomes evaluated before and after treatment were OSDI (Ocular Surface Disease Index) and SANDE (Symptom Assessment in Dry Eye) Questionnaires, VAS (Visual Analog Scale), Slit-Lamp Examination, Esthesiometry, Lissamine Green Staining, NIBUT (Non-Invasive Break-Up Time) and BUT, Fluorescein Staining with Photography and Oxford Classification, Schirmer Test, Best-Corrected Visual Acuity (BCVA), Meibography. We observed a significant improvement in SANDE, VAS and OSDI questionnaires, Schirmer Test, BUT, BCVA, and Oxford classification after treatment with allogeneic cord blood serum eyedrops. Clinical variables, such as corneal inflammation, conjunctivalization, corneal neovascularization, or pain, were also considered individually. Nevertheless, pain and inflammation reduced markedly over time until completely healed in all cases. Our study highlights the remarkable efficacy of allogeneic cord blood serum eyedrops in patients with severe Dry Eye Disease who have shown absent or inadequate response to usual treatments for dry eye. This underscores the need for further comprehensive investigations in this field.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dry Eye SyndromesOphthalmic SolutionsFetal BloodSerumHumansMaleFemaleMiddle AgedAdultAgedAged, 80 and overAdolescentYoung AdultRetrospective StudiesTreatment OutcomeGraft vs Host Disease

Stichwörter der Autor:innen

Stevens-Johnson syndromeadvanced therapies for dry eyeallogeneic cord blood serumfilamentary keratitisgraft-versus-host diseaseneurotrophic keratitisregenerative medicinesevere dry eye disease

Substanzen

Ophthalmic Solutions

Autor:innen und Institutionen

  • Department of Ophthalmology, University Hospital of Udine, 33100 Udine, Italy.
  • Department of Medicine, Surgery and Health Sciences, University of Trieste, 34127 Trieste, Italy.
  • Department of Ophthalmology, University of Catania, 95123 Catania, Italy.
  • Department of Medicine and Surgery, University of Enna "Kore", Piazza dell'Università, 94100 Enna, Italy.
  • Eye Center "G.B. Morgagni-DSV", 95125 Catania, Italy.
  • Sciacca Cord Blood Bank, 92019 Sciacca, Italy.

ORCID-Profile: Marco Zeppieri, Giuseppe Gagliano, Matteo Capobianco, Caterina Gagliano, Francesco Cappellani, Alessandro Avitabile, Ludovica Cannizzaro, Fabiana D'Esposito

Zitieren

APA

Zeppieri, M., Gagliano, G., Capobianco, M., Gagliano, C., Cappellani, F., Tancredi, G., Avitabile, A., Cannizzaro, L., & D'Esposito, F. (2025). Allogeneic Umbilical Cord Blood Serum Eyedrops for the Treatment of Severe Dry Eye Disease Patients. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms262110782

Vancouver

Zeppieri M, Gagliano G, Capobianco M, Gagliano C, Cappellani F, Tancredi G, et al. Allogeneic Umbilical Cord Blood Serum Eyedrops for the Treatment of Severe Dry Eye Disease Patients. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms262110782

BibTeX
@article{Zeppieri2025,
  author = {Zeppieri, Marco and Gagliano, Giuseppe and Capobianco, Matteo and Gagliano, Caterina and Cappellani, Francesco and Tancredi, Giuseppa and Avitabile, Alessandro and Cannizzaro, Ludovica and D'Esposito, Fabiana},
  title = {Allogeneic Umbilical Cord Blood Serum Eyedrops for the Treatment of Severe Dry Eye Disease Patients},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms262110782}
}
Kostenlos starten →